Evidence map›Paper›PMID 39853555›Full record

ArticleJournal of materials science. Materials in medicine2025

Unraveling the immunomodulatory and metabolic effects of bioactive glass S53P4 on macrophages in vitro.

Karoliina Kajander, Nicole Nowak, Negin Vaziri, Pekka K Vallittu, Terhi J Heino, Jorma A Määttä

Abstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Developing anACS pharmacology & translational science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karoliina KajanderInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland. karoliina.kajander@utu.fi.ORCID http://orcid.org/0000-0002-5832-7159
Nicole NowakInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
Negin VaziriInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
Pekka K VallittuDepartment of Biomaterials Science and Turku Clinical Biomaterials Centre - TCBC, Institute of Dentistry, University of Turku, Turku, Finland.
Terhi J HeinoInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
Jorma A MäättäInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland. jmaatta@utu.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage metabolism is closely linked to their phenotype and function, which is why there is growing interest in studying the metabolic reprogramming of macrophages. Bioactive glass (BG) S53P4 is a bioactive material used especially in bone applications. Additionally, BG S53P4 has been shown to affect macrophages, but the mechanisms through which the possible immunomodulatory effects are conveyed remain unclear. According to the results presented here, the lipopolysaccharide (LPS) induced suppression in oxidative phosphorylation is rescued in macrophages cultured with BG S53P4 before the inflammatory stimulus. Additionally, BG S53P4-exposed macrophages expressed lower mRNA levels of inflammatory cytokines Il6 and Il1b, as well as demonstrated decreased activation of inflammatory interferon regulatory factor (IRF) and NF-κB pathways and nitrogen oxide secretion in response to LPS. These results did not rely on cells being in direct contact with the material as similar effects were observed in the presence of BG S53P4-conditioned medium. Our findings link the immunomodulatory properties of BG S53P4 and macrophage metabolism, which improves our understanding of the mechanisms underlying the clinical efficacy of bioactive glasses.

Indexed as

GlassImmunologic FactorsMacrophagesAnimalsBiocompatible MaterialsCytokinesImmunomodulationLipopolysaccharidesMiceNF-kappa BOxidative PhosphorylationRAW 264.7 Cellsbioactive glass S53P4Biocompatible MaterialsCytokinesImmunologic FactorsLipopolysaccharidesNF-kappa B

Identifiers

PMID39853555
PMCPMC11762225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.